More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities
By Andrew Powaleny | June 22, 2021
We are in a new era of medicine where groundbreaking biopharmaceutical research and development is transforming medicine, but these innovations are meaningless if they don’t reach patients,...
Read More
New PhRMA report shows nearly 90 medicines in development to fight drug-resistant infections, but future pipeline remains challenging
By Andrew Powaleny | April 29, 2021
The discovery and introduction of antibiotics in the 1940s transformed modern medicine and enabled tremendous progress in health care and life expectancy. Today, this progress is being threatened...
Read More
Report: More than 1,300 medicines and vaccines in development to help fight cancer
By Andrew Powaleny | December 15, 2020
Over the last 30 years, significant progress has been made in the fight against cancer. Researchers have expanded their understanding of how cancer develops and how to target medicines for...
Read More
New report shows nearly 260 vaccines in development, including dozens for COVID-19
By Andrew Powaleny | April 23, 2020
Vaccines represent some of the most impactful advances in public health, helping to prevent the spread of many infectious diseases and, in many parts of the world, eliminating some of the most...
Read More
Nearly 400 cell and gene therapies in development to target a broad range of diseases
By Andrew Powaleny | March 10, 2020
In 2017, the U.S. approved its first cell and gene therapy, making the idea of altering a gene to cure or treat a disease a reality. As the increasing pace of R&D propels cell and gene therapy...
Read More
Nearly 140 medicines in development to treat mental illness
By Andrew Powaleny | October 10, 2019
Today is World Mental Health Day, a moment where we reflect about the challenges we still face towards better treatment of mental illness and its impact on patients.
Read More
New report shows more than 160 medicines in development for diabetes and related conditions
By Andrew Powaleny | April 24, 2019
Diabetes represents a significant public health issue in the U.S. It affects more than 30 million Americans, including around 7.2 million who are undiagnosed. Additionally, there are close to 1.5...
Read More
New report shows nearly 20 innovative medicines in development for sickle cell disease
By Andrew Powaleny | April 2, 2019
Sickle cell disease (SCD) is the most common inherited blood disorder in the United States, afflicting nearly 100,000 Americans. Patients with SCD have sickle-shaped red blood cells, which have...
Read More
130 medicines in development for asthma, allergies and other respiratory diseases
By Andrew Powaleny | February 21, 2019
Millions of Americans suffer from respiratory diseases, including Asthma and chronic obstructive pulmonary disease (COPD). Together, these two diseases affect the day-to-day lives of over 40...
Read More
New report shows nearly 300 cell and gene therapies in development
By Andrew Powaleny | December 6, 2018
Fifty years ago, the idea of altering a gene to treat or even cure a disease was considered science fiction. Today, cell and gene therapy are transforming treatment options for some patients and...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
